| Autor: |
Teerlink, J.R. Metra, M. Filippatos, G.S. Davison, B.A. Bartunek, J. Terzic, A. Gersh, B.J. Povsic, T.J. Henry, T.D. Alexandre, B. Homsy, C. Edwards, C. Seron, A. Wijns, W. Cotter, G. for the CHART Investigators |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Popis: |
Aims: Left ventricular (LV) reverse remodelling is an important marker of improved outcomes in patients with advanced heart failure (HF). We examined the impact of the intramyocardial administration of bone-marrow-derived, lineage-directed, autologous cardiopoietic mesenchymal stem cells (C3BS-CQR-1) on LV remodelling in patients with advanced HF enrolled in the CHART-1 study. Methods and results: Patients (n=351) with symptomatic advanced HF secondary to ischaemic heart disease, and reduced LV ejection fraction (LVEF |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
